More Articles
Surmodics, a Minnesota-based healthcare technology company, has received U.S. Food and Drug Administration (FDA) approval for its SurVeil drug-coated balloon (DCB).
…
The U.S. Department of Justice (DOJ) has announced that a North Carolina cardiologist and his practice, Carolina Heart and Leg Center, agreed to…
Surmodics, a Minnesota-based healthcare technology company, has received U.S. Food and Drug Administration (FDA) clearance for a new interventional device designed to remove thrombi and emboli from…
Bitterroot Bio, a new California-based biotechnology company, has stepped out of the shadows and officially announced its presence to the public after first forming back in 2021. The company was launched by a team physicians,…
Warfarin use after transcatheter aortic valve replacement (TAVR) is not associated with significantly different medium-term patient…
An Indiana cardiologist has been ordered by a jury to pay $2.6 million in damages after a cardiac catheterization gone wrong left a patient’s leg permanently disfigured.
Shashi Ahuja, MD, performed…
A new-look embolic protection device from Nevada-based EnCompass Technologies has been used for the very first time to help cardiologists complete…
Vegetarian and vegan diets are both associated with a reduced risk of cardiovascular disease (CVD) caused by blocked arteries, according to a new systematic review and meta-analysis published in European Heart Journal.[1]…
Marijuana users are much more likely to have peripheral artery disease (PAD) than nonusers, according to new data presented Thursday, May 18, at the Society for Cardiovascular…
The number of deaths around the world due to ischemic stroke is expected to increase significantly in the years ahead, according to new research published in Neurology.[1] In fact, researchers anticipate the number could jump…
Asundexian, a new investigational drug from Bayer, is now one step closer to being approved by the U.S. Food and Drug Administration (FDA) to treat atrial fibrillation (AFib).
…
Two massive names in healthcare, Medtronic and Johnson & Johnson, are interested in a potential acquisition of Shockwave Medical, the California-based company known for its intravascular lithotripsy (IVL) technology, according to…
Boston Scientific has been exploring a potential acquisition of Shockwave Medical, the…
Cardiologists employed by a hospital are much more likely to perform high-intensity coronary interventions on heart patients presenting with stable angina than independent cardiologists, according to new research published in …
Abbott has completed its acquisition of Cardiovascular Systems (CSI), a Minnesota-based healthcare technology company focused on treating peripheral artery disease (PAD) and coronary artery disease (CAD).
…
Florida-based network of outpatient vascular centers partners with 2 private equity investment firms
American Vascular Associates (AVA), a Palm Harbor, Florida-based network of outpatient vascular and endovascular facilities, has received a significant boost from two private equity investment firms.
…
Medtronic’s Endurant abdominal aortic aneurysm (AAA) stent graft system for endovascular aneurysm repair (EVAR) is associated with strong 10-year outcomes, according to new real-world data presented at the…
HeartFlow has announced the U.S. launch of RoadMap Analysis, a new artificial intelligence (AI) solution able to identify stenoses in patients with…
Intravascular ultrasound (IVUS) and optical coherence tomography (OCT) are the two most common intravascular imaging systems used in cardiac cath labs to offer detailed views inside coronary vessels. However, there are limitations to these…
